AGIO251017P00040000 Option on Agios Pharm

AGIO Stock  USD 39.66  0.26  0.65%   
AGIO251017P00040000 is a PUT option contract on Agios Pharm's common stock with a strick price of 40.0 expiring on 2025-10-17. The contract was not traded in recent days and, as of today, has 87 days remaining before the expiration. The option is currently trading at a bid price of $2.0, and an ask price of $4.9. The implied volatility as of the 22nd of July is 87.0.
A put option written on Agios Pharm becomes more valuable as the price of Agios Pharm drops. Conversely, Agios Pharm's put option loses its value as Agios Stock rises.

Rule 16 of 2025-10-17 Option Contract

The options market is anticipating that Agios Pharm will have an average daily up or down price movement of about 0.0288% per day over the life of the option. With Agios Pharm trading at USD 39.66, that is roughly USD 0.0114. If you think that the market is fully understating Agios Pharm's daily price movement you should consider buying Agios Pharm options at that current volatility level of 0.46%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Out Of The Money Put Option on Agios Pharm

An 'Out of The Money' option on Agios has a strike price that Agios Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Agios Pharm's 'Out of The Money' options include buying the options if you expect a big move in Agios Pharm's stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.
Put Contract NameAGIO251017P00040000
Expires On2025-10-17
Days Before Expriration87
Vega0.077304
Gamma0.044214
Theoretical Value3.45
Open Interest1
Strike Price40.0
Last Traded At4.4
Current Price Spread2.0 | 4.9
Rule 16 Daily Up or DownUSD 0.0114

Agios short PUT Option Greeks

Agios Pharm's Option Greeks for the contract ending on 2025-10-17 at a strike price of 40.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Agios Pharm's option greeks, its implied volatility helps estimate the risk of Agios Pharm stock implied by the prices of the options on Agios Pharm's stock.
Delta-0.445628
Gamma0.044214
Theta-0.018191
Vega0.077304
Rho-0.041651

Agios long PUT Option Payoff at expiration

Put options written on Agios Pharm grant holders of the option the right to sell a specified amount of Agios Pharm at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Agios Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Agios Pharm is like buying insurance aginst Agios Pharm's downside shift.
   Profit   
       Agios Pharm Price At Expiration  

Agios short PUT Option Payoff at expiration

By selling Agios Pharm's put option, the investors signal their bearish sentiment. A short position in a put option written on Agios Pharm will generally make money when the underlying price is above the strike price. Therefore Agios Pharm's put payoff at expiration depends on where the Agios Stock price is relative to the put option strike price. The breakeven price of 36.55 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Agios Pharm's price. Finally, at the strike price of 40.0, the payoff chart is constant and positive.
   Profit   
       Agios Pharm Price At Expiration  
View All Agios Pharm Options

Agios Pharm Available Put Options

Agios Pharm's option chain is a display of a range of information that helps investors for ways to trade options on Agios. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Agios. It also shows strike prices and maturity days for a Agios Pharm against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
 Put
AGIO251017P00085000085.043.9 - 47.043.9In
 Put
AGIO251017P00080000080.038.5 - 42.038.5In
 Put
AGIO251017P00075000075.033.7 - 37.533.7In
 Put
AGIO251017P00070000070.029.0 - 32.029.0In
 Put
AGIO251017P00065000065.023.7 - 27.023.7In
 Put
AGIO251017P00060000060.019.2 - 22.019.2In
 Put
AGIO251017P00055000055.014.1 - 17.414.1In
 Put
AGIO251017P00050000050.010.4 - 13.210.4In
 Put
AGIO251017P00045000045.05.4 - 9.45.4In
 Put
AGIO251017P00040000140.02.0 - 4.94.4Out
 Put
AGIO251017P0003500030035.00.55 - 3.90.55Out
 Put
AGIO251017P00025000125.00.0 - 0.71.7Out
 Put
AGIO251017P00022500322.50.0 - 0.750.5Out
 Put
AGIO251017P00020000720.00.0 - 0.750.45Out
 Put
AGIO251017P00017500917.50.0 - 3.80.35Out
 Put
AGIO251017P00015000415.00.0 - 3.83.8Out

Agios Pharm Corporate Management

DSc FRSCCoFounder BoardProfile
Dr DACVPConsultantProfile
Sarah MDChief DevelopmentProfile
James BurnsCorporate OfficerProfile
Ellen LoPrestivChief OfficerProfile
Clive PatienceChief OfficerProfile
ShinSan SuCoFounder BoardProfile
When determining whether Agios Pharm offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agios Pharm's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agios Pharm Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agios Pharm Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agios Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agios Pharm. If investors know Agios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agios Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
11.54
Revenue Per Share
0.649
Quarterly Revenue Growth
0.066
Return On Assets
(0.23)
Return On Equity
0.6026
The market value of Agios Pharm is measured differently than its book value, which is the value of Agios that is recorded on the company's balance sheet. Investors also form their own opinion of Agios Pharm's value that differs from its market value or its book value, called intrinsic value, which is Agios Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agios Pharm's market value can be influenced by many factors that don't directly affect Agios Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agios Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agios Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agios Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.